A multicenter retrospective chart review assessing clean intermittent catheterization rate after treatment with OnabotulinumtoxinA in patients with overactive bladder
Latest Information Update: 08 Nov 2019
Price :
$35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 09 Jun 2016 New trial record
- 10 May 2016 Interim results (n=143) presented at the 111th Annual Meeting of the American Urological Association